EP2120987 - TREATING STROKE AND OTHER DISEASES WITHOUT INHIBITING N-TYPE CALCIUM CHANNELS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 21.11.2014 Database last updated on 02.09.2024 | Most recent event Tooltip | 15.07.2016 | Lapse of the patent in a contracting state New state(s): LU, TR | published on 17.08.2016 [2016/33] | Applicant(s) | For all designated states NoNO Inc. 88 Strath Avenue Toronto ON M8X 1R5 / CA | [2012/26] |
Former [2012/19] | For all designated states NoNO, Inc. 88 Strath Avenue Toronto ON M8X 1R5 / CA | ||
Former [2009/48] | For all designated states Arbor Vita Corporation 772 Lucerne Drive Sunnyvale, CA 94085 / US | ||
For all designated states Nono Inc. 88 Strath Avenue Toronto, ON M8X 1R5 / CA | Inventor(s) | 01 /
BELMARES, Michael, P. 772 Lucerne Drive Sunnyvale, CA 94085 / US | 02 /
GARMAN, Jonathan, David 772 Lucerne Drive Sunnyvale, CA 94085 / US | 03 /
LU, Peter, S. 772 Lucerne Drive Sunnyvale, CA 94085 / US | 04 /
SALTER, Michael, W. 88 Strath Avenue Toronto, Ontario, M8X 1R5 / CA | 05 /
TYMIANSKI, Michael 88 Strath Avenue Toronto, Ontario, M8X 1R5 / CA | [2009/48] | Representative(s) | Green, Mark Charles, et al Murgitroyd & Company London Euston House 24 Eversholt Street London NW1 1AD / GB | [N/P] |
Former [2014/03] | Green, Mark Charles, et al Urquhart-Dykes & Lord LLP 3rd Floor 33 Glasshouse Street London W1B 5DG / GB | ||
Former [2009/48] | Green, Mark Charles, et al Urquhart-Dykes & Lord LLP 30 Welbeck Street London W1G 8ER / GB | Application number, filing date | 08726313.3 | 29.02.2008 | [2009/48] | WO2008US02754 | Priority number, date | US20070904507P | 02.03.2007 Original published format: US 904507 P | [2009/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008109010 | Date: | 12.09.2008 | Language: | EN | [2008/37] | Type: | A1 Application with search report | No.: | EP2120987 | Date: | 25.11.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.09.2008 takes the place of the publication of the European patent application. | [2009/48] | Type: | B1 Patent specification | No.: | EP2120987 | Date: | 15.01.2014 | Language: | EN | [2014/03] | Search report(s) | International search report - published on: | US | 12.09.2008 | (Supplementary) European search report - dispatched on: | EP | 16.07.2010 | Classification | IPC: | A61K38/00, A61K38/04, A61K38/10, A61K38/16, C07K14/435 | [2009/48] | CPC: |
C07K14/70571 (EP,US);
C07K7/06 (US);
A61K47/645 (EP,US);
A61P25/00 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2009/48] | Title | German: | BEHANDLUNG VON SCHLAGANFALL UND ANDEREN KRANKHEITEN OHNE HEMMUNG VON N-CALCIUM-KANÄLEN | [2009/48] | English: | TREATING STROKE AND OTHER DISEASES WITHOUT INHIBITING N-TYPE CALCIUM CHANNELS | [2009/48] | French: | TRAITEMENT DES INCIDENTS CÉRÉBROVASCULAIRES ET D'AUTRES MALADIES SANS INHIBITION DES CANAUX CALCIUM DE TYPE N | [2009/48] | Entry into regional phase | 03.09.2009 | National basic fee paid | 03.09.2009 | Search fee paid | 03.09.2009 | Designation fee(s) paid | 03.09.2009 | Examination fee paid | Examination procedure | 03.09.2009 | Examination requested [2009/48] | 09.02.2011 | Amendment by applicant (claims and/or description) | 28.11.2011 | Despatch of a communication from the examining division (Time limit: M04) | 28.02.2012 | Reply to a communication from the examining division | 14.12.2012 | Despatch of a communication from the examining division (Time limit: M06) | 17.05.2013 | Reply to a communication from the examining division | 15.07.2013 | Communication of intention to grant the patent | 23.10.2013 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 23.10.2013 | Fee for grant paid | 23.10.2013 | Fee for publishing/printing paid | 22.11.2013 | Communication of intention to grant the patent | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 28.11.2011 | Opposition(s) | 16.10.2014 | No opposition filed within time limit [2014/52] | Fees paid | Renewal fee | 08.02.2010 | Renewal fee patent year 03 | 15.02.2011 | Renewal fee patent year 04 | 15.02.2012 | Renewal fee patent year 05 | 12.02.2013 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 29.02.2008 | AT | 15.01.2014 | BE | 15.01.2014 | BG | 15.01.2014 | CY | 15.01.2014 | CZ | 15.01.2014 | EE | 15.01.2014 | FI | 15.01.2014 | HR | 15.01.2014 | LT | 15.01.2014 | LV | 15.01.2014 | MC | 15.01.2014 | MT | 15.01.2014 | PL | 15.01.2014 | RO | 15.01.2014 | SI | 15.01.2014 | SK | 15.01.2014 | TR | 15.01.2014 | LU | 28.02.2014 | NO | 15.04.2014 | GR | 16.04.2014 | IS | 15.05.2014 | PT | 15.05.2014 | [2016/33] |
Former [2016/32] | HU | 29.02.2008 | |
AT | 15.01.2014 | ||
BE | 15.01.2014 | ||
BG | 15.01.2014 | ||
CY | 15.01.2014 | ||
CZ | 15.01.2014 | ||
EE | 15.01.2014 | ||
FI | 15.01.2014 | ||
HR | 15.01.2014 | ||
LT | 15.01.2014 | ||
LV | 15.01.2014 | ||
MC | 15.01.2014 | ||
MT | 15.01.2014 | ||
PL | 15.01.2014 | ||
RO | 15.01.2014 | ||
SI | 15.01.2014 | ||
SK | 15.01.2014 | ||
NO | 15.04.2014 | ||
GR | 16.04.2014 | ||
IS | 15.05.2014 | ||
PT | 15.05.2014 | ||
Former [2016/28] | AT | 15.01.2014 | |
BE | 15.01.2014 | ||
BG | 15.01.2014 | ||
CY | 15.01.2014 | ||
CZ | 15.01.2014 | ||
EE | 15.01.2014 | ||
FI | 15.01.2014 | ||
HR | 15.01.2014 | ||
LT | 15.01.2014 | ||
LV | 15.01.2014 | ||
MC | 15.01.2014 | ||
MT | 15.01.2014 | ||
PL | 15.01.2014 | ||
RO | 15.01.2014 | ||
SI | 15.01.2014 | ||
SK | 15.01.2014 | ||
NO | 15.04.2014 | ||
GR | 16.04.2014 | ||
IS | 15.05.2014 | ||
PT | 15.05.2014 | ||
Former [2016/25] | AT | 15.01.2014 | |
BE | 15.01.2014 | ||
BG | 15.01.2014 | ||
CY | 15.01.2014 | ||
CZ | 15.01.2014 | ||
EE | 15.01.2014 | ||
FI | 15.01.2014 | ||
HR | 15.01.2014 | ||
LT | 15.01.2014 | ||
LV | 15.01.2014 | ||
MC | 15.01.2014 | ||
MT | 15.01.2014 | ||
PL | 15.01.2014 | ||
RO | 15.01.2014 | ||
SI | 15.01.2014 | ||
SK | 15.01.2014 | ||
NO | 15.04.2014 | ||
IS | 15.05.2014 | ||
PT | 15.05.2014 | ||
Former [2016/12] | AT | 15.01.2014 | |
BE | 15.01.2014 | ||
CY | 15.01.2014 | ||
CZ | 15.01.2014 | ||
EE | 15.01.2014 | ||
FI | 15.01.2014 | ||
HR | 15.01.2014 | ||
LT | 15.01.2014 | ||
LV | 15.01.2014 | ||
MC | 15.01.2014 | ||
MT | 15.01.2014 | ||
PL | 15.01.2014 | ||
RO | 15.01.2014 | ||
SI | 15.01.2014 | ||
SK | 15.01.2014 | ||
NO | 15.04.2014 | ||
IS | 15.05.2014 | ||
PT | 15.05.2014 | ||
Former [2015/24] | AT | 15.01.2014 | |
BE | 15.01.2014 | ||
CY | 15.01.2014 | ||
CZ | 15.01.2014 | ||
EE | 15.01.2014 | ||
FI | 15.01.2014 | ||
HR | 15.01.2014 | ||
LT | 15.01.2014 | ||
LV | 15.01.2014 | ||
MC | 15.01.2014 | ||
PL | 15.01.2014 | ||
RO | 15.01.2014 | ||
SI | 15.01.2014 | ||
SK | 15.01.2014 | ||
NO | 15.04.2014 | ||
IS | 15.05.2014 | ||
PT | 15.05.2014 | ||
Former [2014/50] | AT | 15.01.2014 | |
BE | 15.01.2014 | ||
CY | 15.01.2014 | ||
CZ | 15.01.2014 | ||
EE | 15.01.2014 | ||
FI | 15.01.2014 | ||
HR | 15.01.2014 | ||
LT | 15.01.2014 | ||
LV | 15.01.2014 | ||
MC | 15.01.2014 | ||
PL | 15.01.2014 | ||
RO | 15.01.2014 | ||
SK | 15.01.2014 | ||
NO | 15.04.2014 | ||
IS | 15.05.2014 | ||
PT | 15.05.2014 | ||
Former [2014/49] | AT | 15.01.2014 | |
BE | 15.01.2014 | ||
CY | 15.01.2014 | ||
CZ | 15.01.2014 | ||
EE | 15.01.2014 | ||
FI | 15.01.2014 | ||
HR | 15.01.2014 | ||
LT | 15.01.2014 | ||
LV | 15.01.2014 | ||
MC | 15.01.2014 | ||
RO | 15.01.2014 | ||
NO | 15.04.2014 | ||
IS | 15.05.2014 | ||
PT | 15.05.2014 | ||
Former [2014/48] | AT | 15.01.2014 | |
BE | 15.01.2014 | ||
CY | 15.01.2014 | ||
CZ | 15.01.2014 | ||
EE | 15.01.2014 | ||
FI | 15.01.2014 | ||
HR | 15.01.2014 | ||
LT | 15.01.2014 | ||
LV | 15.01.2014 | ||
MC | 15.01.2014 | ||
NO | 15.04.2014 | ||
IS | 15.05.2014 | ||
PT | 15.05.2014 | ||
Former [2014/46] | AT | 15.01.2014 | |
BE | 15.01.2014 | ||
CY | 15.01.2014 | ||
FI | 15.01.2014 | ||
HR | 15.01.2014 | ||
LT | 15.01.2014 | ||
LV | 15.01.2014 | ||
MC | 15.01.2014 | ||
NO | 15.04.2014 | ||
IS | 15.05.2014 | ||
PT | 15.05.2014 | ||
Former [2014/41] | AT | 15.01.2014 | |
BE | 15.01.2014 | ||
CY | 15.01.2014 | ||
FI | 15.01.2014 | ||
HR | 15.01.2014 | ||
LT | 15.01.2014 | ||
LV | 15.01.2014 | ||
NO | 15.04.2014 | ||
IS | 15.05.2014 | ||
PT | 15.05.2014 | ||
Former [2014/37] | AT | 15.01.2014 | |
CY | 15.01.2014 | ||
FI | 15.01.2014 | ||
LT | 15.01.2014 | ||
NO | 15.04.2014 | ||
IS | 15.05.2014 | ||
PT | 15.05.2014 | ||
Former [2014/36] | LT | 15.01.2014 | |
NO | 15.04.2014 | ||
IS | 15.05.2014 | Documents cited: | Search | [A]WO0149832 (ARTEMIS PHARMACEUTICALS GMBH [DE]) [A] 1-15 * claim 5; sequence 19 *; | [X]WO03076561 (ARTEMIS PHARMACEUTICALS GMBH [DE], et al) [X] 11,13-15 * claims 1-11; sequence 41 *; | [X]WO2005035562 (YAMANAKA SHINYA [JP], et al) [X] 11,13-15 * sequences 10, 14 *; | [A]WO2006084179 (CHIRON CORP [US], et al) [A] 1-15 * figure 7 *; | [AP] - JOURNAL OF NEUROSCIENCE, (200709), vol. 27, no. 37, ISSN 0270-6474, pages 9901 - 9915, XP002581414 [AP] 1-15 DOI: http://dx.doi.org/10.1523/jneurosci.1464-07.2007 | [A] - HSU CHUN ET AL, "Perturbing NMDA receptor - PSD-95 protein interactions prevents selective loss of nitric oxide synthase (NOS) containing neuron in rat gastric myenteric plexus", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200604), Database accession no. PREV200600502290, XP009133060 [A] 1-15 * abstract * | [ ] - GASTROENTEROLOGY, DIGESTIVE DISEASE WEEK MEETING/107TH ANNUAL MEETING OF THE AMERICAN-GASTROENTEROLOGICAL-ASSOCIATION; LOS ANGELES, CA, USA; MAY 19 24, 2006, (200604), vol. 130, no. 4, Suppl. 2, ISSN 0016-5085, page A30 | [A] - AARTS MICHELLE ET AL, "Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US LNKD- DOI:10.1126/SCIENCE.1072873, (20021025), vol. 298, no. 5594, ISSN 0036-8075, pages 846 - 850, XP002476284 [A] 1-15 DOI: http://dx.doi.org/10.1126/science.1072873 | [A] - LIU Y ET AL, "UNCOUPLING NMDA RECEPTOR - PSD - 95 PROTEIN INTERACTIONS REDUCES INFARCTION IN FOCAL CEREBRAL ISCHEMIA IN RATS.", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (2002), Database accession no. PREV200300283348, XP009133058 [A] 1-15 * abstract * | [ ] - SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, 32ND ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE; ORLANDO, FLORIDA, USA; NOVEMBER 02-07, 2002, (2002), vol. 2002, pages Abstract No. 245.3 URL - http://sf | [A] - AARTS M M ET AL, "UNCOUPLING OF NMDAR SIGNALING FROM NEUROTOXICITY BY TAT - FUSION PEPTIDES.", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (2002), Database accession no. PREV200300283347, XP009133059 [A] 1-15 * abstract * | [ ] - SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, 32ND ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE; ORLANDO, FLORIDA, USA; NOVEMBER 02-07, 2002, (2002), vol. 2002, pages Abstract No. 245.2 URL - http://sf | International search | [A] - TYAGI ET AL., "Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans", J. BIOLOGICAL CHEMISTRY, (20010202), vol. 276, no. 5, pages 3254 - 3261, XP008116001 DOI: http://dx.doi.org/10.1074/jbc.M006701200 |